This message was sent to ##Email##
|
|
|
|
|
Join the American Society of Transplantation (AST), the European Society for Organ Transplantation (ESOT), and The Transplantation Society (TTS) for the International Transplantation Science (ITS) meeting in Clearwater Beach, Florida. Online registration will end on November 8, so register today.
We just launched the 2019 COP giving contest: The Donation Derby. Watch this race, as the COPs compete for two prizes and fundraise for their upcoming initiatives. All donations made by COP members until the end of the year will count toward this contest, so be sure to check it out today.
READ MORE
The AST is now accepting nominations for its 2020 Board of Directors. If you are interested in joining the AST Board, or know someone who is, we encourage you to submit your nomination. Learn more about the election process here.
 |
|
Promoted by
Veloxis Pharmaceuticals
Explore some of the many factors that can put a graft at risk, including CYP3A5*1 expression, declining adherence, and nephrotoxicity. In addition, review pharmacokinetic and clinical data that may be relevant to your practice and patients.
See the Video
|
|
Know someone in need of a college scholarship? The American Society of Transplantation is seeking creative content that helps raise awareness in specific areas of transplantation for its Power2Save initiative.
READ MORE
Join us for an interactive discussion on organ allocation at the 2020 Cutting Edge of Transplantation (CEoT) meeting in Phoenix, AZ. Early bird registration is now open.
READ MORE
Advertisement
Veloxis Pharmaceuticals
There are many factors that may put a graft at risk, such as infections, nephrotoxicity, declining adherence, and inadequate immunosuppression. It can be difficult to achieve a balance between overimmunosuppression and underimmunosuppression in kidney transplant patients, putting patients at risk.
Learn more
|
The Women’s Health COP (WHCOP) often receives requests for recommended conference speakers and content experts for educational projects such as webinars. To identify and highlight members throughout our society, we are creating a Women Speakers List of AST members and their areas of expertise. Submit Nomination
| Brand new patient resources
|
    |
The Pediatric Community of Practice (PCOP) recently completed several educational documents including HPI- PV Vaccine Information for Patients and Parents, Pneumococcal Flyer for Parents (Pediatric), Pneumococcal Flyer for Physicians/Providers, and DASH Diet for Pediatric Transplant Recipients.
The Transplant Nephrology Core Curriculum (TNCC) is an online program jointly provided by the American Society of Nephrology and the American Society of Transplantation. The TNCC focuses on key information needed to prepare for the American Board of Internal Medicine Nephrology Board Certification and Maintenance of Certification examinations.
READ MORE
| Upcoming Education Events
|
|
Sexual Health and Monitoring Recommendations for Transplant Recipients
November 6, 2019 | 2 pm ET | Online Activity
November 21, 2019 | 3 pm ET | Online Activity
|
|
The Journal of Clinical Investigation
Impaired T cell immunity in transplant recipients is associated with infection-related morbidity and mortality. We recently reported the successful use of adoptive T cell therapy (ACT) against drug-resistant/recurrent cytomegalovirus in solid-organ transplant recipients.
READ MORE
JAMA
In this simulation study of 524,359 potential organ recipients in a decision analytical model, a presumed consent policy was estimated to be associated with a reduction in waiting list removals. This estimation translated to an increase in life-years gained for patients in this simulation.
READ MORE
|
KidneyCare combines clinically validated AlloSure testing with AlloMap kidney and iBox to deliver personalized and Prognostic solutions for transplant patients.
Learn More
|
|
|
|
|
TruGraf® - The 1st and only non-invasive test to rule out “silent" subclinical rejection in stable kidney transplant recipients
The only test to be reimbursed as an alternative to surveillance biopsies
Developed by Clinicians for Clinicians
Learn More
|
|
|
|
|
American Journal of Transplantation
Vaccination against human papillomavirus (HPV) is recommended to prevent new HPV infections and HPV‐associated diseases, including some cancers. The Advisory Committee on Immunization Practices (ACIP)* routinely recommends HPV vaccination at age 11 or 12 years; vaccination can be given starting at age 9 years
READ MORE
AASLD
Patients listed or being evaluated for solid organ transplant after January 26, 2018 were educated and consented by protocol on the transplantation of HCV viremic organs. All recipients were HCV nucleic acid test (NAT) and anti‐HCV antibody negative at the time of transplant and received an HCV viremic organ. The primary outcome was sustained virologic response at 12 weeks after completion of DAA therapy (SVR12).
READ MORE
|
Advertisement
Decades of clinical evidence has shown that HLA-specific antibodies may lead to hyperacute antibody-mediated rejection (ABMR).
Today, ABMR remains a major challenge to successful transplantation, but detection of donor specific antibodies (DSA) is the best tool for stratifying risk. LABScreen Single Antigen Beads remain the worldwide leader for the detection of DSA.
Learn More
|
|
|
|
|
Reach Your Prospects Every Week
Thousands of industry professionals subscribe to association news briefs, which allows your company to push messaging directly to their inboxes and take advantage of the association's brand affinity.
Connect with Highly Defined Buyers and Maximize Your Brand Exposure
|
|
|
|
|
AASLD
Included were LT recipients from 2014‐16 who had a pre‐LT frailty assessment using the Liver Frailty index (LFI). Frailty was defined as a LFI ≥ 4.5. ACR at 3 months was ascertained from pathology reports and immunosuppression regimens were collected from chart review.
READ MORE
|
|
|
7701 Las Colinas Ridge, Ste. 800, Irving, TX 75063
|
